Jay V Ihlenfeld - 09 May 2025 Form 4 Insider Report for Celanese Corp (CE)

Reporting relationship: Director
Issuer ticker: CE
Reported as of: 09 May 2025
Net transaction value: +$306
SEC form: 4
Accepted by SEC: 13 May 2025, 16:21:02 UTC
Prior SEC filing: 13 Mar 2025
Next SEC filing: 13 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Christine Dryden, Attorney-in-Fact for Jay V. Ihlenfeld

Key filing fact

Jay V Ihlenfeld filed Form 4 for Celanese Corp (CE) on 13 May 2025.

Key facts

This page summarizes Jay V Ihlenfeld's Form 4 filing for Celanese Corp (CE).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 13 May 2025, 16:21.

Change

Previous filing in this sequence was filed on 13 Mar 2025.
Current net transaction value: +$306.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001205395 Primary reporting owner

IHLENFELD JAY V

Relationship: Director
Address: C/O CELANESE CORPORATION, 222 W. LAS COLINAS BLVD., SUITE 900N, IRVING
Signature: /s/ Christine Dryden, Attorney-in-Fact for Jay V. Ihlenfeld
Signature date: 13 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CE transaction

Common Stock

Award

Transaction value: $0
Shares: +3,376
Change %: +27%
Price: $0.000000
Shares after: 15,850
Date: 09 May 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CE transaction Derivative

Phantom Stock

Award

Transaction value: $306
Shares: +6
Change %: +0.06%
Price: $54.53
Shares after: 10,221
Date: 12 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Annual grant of restricted stock units pursuant to the Company's Amended and Restated 2018 Global Incentive Plan. The restricted stock units vest in full on the one-year anniversary of the date of grant.

Footnote F2

Each share of phantom stock represents the right to receive one share of Common Stock.

Footnote F3

The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company.